Trial intelligence / Profile preview

A006 Dose-Ranging Study in Adult Asthma

NCT01581177Phase 2Completed

Start
Apr 2012
Primary completion
Jul 2012
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of albuterol dry powder inhaler in asthma (7 arms). Primary endpoint: Change in FEV1 Area Under the Curve versus placebo. Started Apr 2012; status: completed.

02

Drugs

albuterol dry powder inhaler
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01581177.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01581177.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call